MedPage Today on MSN
Bispecifics Before CAR-T May Be Best-Bet Sequence for Large B-Cell Lymphoma
The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback